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Summary Shigella dysenteriae type 1 (Sd1) represents a particular threat in developing
countries because of the severity of the infection and its epidemic potential. Antimicrobial
susceptibility testing and molecular subtyping by pulsed-ﬁeld gel electrophoresis (PFGE) and
plasmid proﬁling (PP) of Sd1 isolates collected during two dysentery outbreaks (2013 and 445
cases of bloody diarrhoea) in Central African Republic (CAR) during the period 2003—2004
were reported. Eleven Sd1 comparison strains (CS) acquired by travellers or residents of Africa
(n = 10) or Asia (n = 1) between 1993 and 2003 were also analysed. The 19 Sd1 isolates recovered
from CAR outbreaks were multidrug resistant, although susceptible to quinolones and ﬂuoro-
quinolones. Molecular subtyping by PFGE was more discriminatory than PP. The PFGE using XbaI
and NotI restriction enzymes indicated that the two outbreaks were due to two different clones
and also revealed a genetic diversity among the CS recovered from outbreak or sporadic cases
between 1993 and 2003. This study was the result of a fruitful collaboration between ﬁeld physi-
cians and microbiologists. The data collected will serve as the basis for establishing long-term
monitoring of Sd1 in CAR.
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1. Introduction
Among Shigella species, Shigella dysenteriae type 1 (Sd1)
is of particular importance, because: (1) Sd1 produces the
Shiga toxin and causes severe infections; (2) Sd1 is asso-
ciated with large dysentery epidemics in developing coun-
tries; and (3) Sd1 strains isolated worldwide are often
multidrug resistant (MDR), with plasmid-mediated resis-
tance to commonly used antimicrobials such as ampi-
cillin, tetracycline, chloramphenicol and sulfamethoxazole-
trimethoprim, whereas additional resistance to quinolones,
due to chromosomal mutation(s) is mainly observed in South
Asia (Dutta et al., 2003b; Pazhani et al., 2004; Sarkar et al.,
2003; Talukder et al., 2004; WHO, 2005).
In 1979, a major epidemic caused by MDR Sd1 started
in North East Zaire (now Democratic Republic of Congo) and
spread rapidly through Zaire, Rwanda, Burundi and Tanzania
by 1981—1982 (Bogaerts et al., 1997; Ebright et al., 1984;
Frost et al., 1981, 1985; Mhalu et al., 1984; Petat et al.,
1987). Afterwards, other MDR Sd1 outbreaks were reported
in Central, East, South and West African countries between
1983 and 2004 (Aragon et al., 1995; Cunin et al., 1999; Diallo
et al., 2001; Engels et al., 1995; Gebre-Yohannes and Drasar,
1990; Goma Epidemiology Group, 1995; Guerin et al., 2003;
Kariuki et al., 1996; Mudzamiri et al., 1996; Pillay et al.,
1997; Ries et al., 1994; Tuttle et al., 1995; WHO, 2003, 2004,
2005).
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2004 in the Kaga-Bandoro area in the Pre´fecture of Nana-
Grebizi in northern CAR, about 350 km from Bangui (Figure 1)
(Me´decins Sans Frontie`res, unpublished results). Outbreak B
involved 445 cases of bloody diarrhoea. A total of 34 deaths
(overall CFR 7.6%) attributed to dysentery were reported.
In this study, we report laboratory data of these two Sd1
dysentery outbreaks, which are to our knowledge the ﬁrst
outbreaks due to MDR Sd1 reported in CAR. Antimicrobial
susceptibility testing and molecular subtyping by plasmid
proﬁling (PP) and pulsed-ﬁeld gel electrophoresis (PFGE)
using enzymes XbaI and NotI were performed on 19 Sd1
strains isolated during these outbreaks. Eleven Sd1 compar-
ison strains (CS) acquired by travellers or residents of Africa
(n = 10) or Asia (n = 1) between 1993 and 2003 were also anal-
ysed.
2. Materials and methods
2.1. Sampling
The investigation of two large outbreaks of dysentery
in CAR during the period 2003—2004 was conducted by
the Me´decins Sans Frontie`res (MSF) team based in Ban-
gui, on behalf of the CAR Public Health Ministry (CPMH).
The mobile teams, composed of personnel from MSF and
CPMH, provided adapted hygiene advice, soaps and treat-
ment, assessed water sources, and collected ﬁeld data
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senteIn 2003—2004, two large outbreaks of dysentery occurred
n two Pre´fectures (administrative subdivisions) of Cen-
ral African Republic (CAR) (WHO, 2003) (Me´decins Sans
rontie`res, unpublished results). CAR is a 623 000 km2
entral African country with an estimated population of
285 000 inhabitants. Outbreak A occurred between July
003 and February 2004 in the Pre´fecture of Ouaham-Pende
n northwest CAR, about 450 km from the capital, Bangui
Figure 1) (WHO, 2003) (Me´decins Sans Frontie`res, unpub-
ished results). In total, 2013 cases of bloody diarrhoea were
eported in the towns of Bozoum and Paoua and in villages
long the 140-km-long road between these towns. Forty-one
eaths attributed to dysentery were recorded during the
utbreak period, giving an overall case fatality rate (CFR) of
.04%. Outbreak B occurred between August and December
Figure 1 Areas affected by epidemic dynd stool samples. The stool samples were placed in Cary-
lair transport medium (Oxoid, Basingstoke, UK) and stored
t 4 ◦C.
.2. Bacterial strains
he stool samples were processed in the Clinical Micro-
iology Laboratory of the Institut Pasteur de Bangui on
he following media: Hektoen (bioMe´rieux, Marcy l’Etoile,
rance), Bromcresol Purple agar plate (bioMe´rieux), Mac
onkey-Sorbitol (Becton-Dickinson, Sparks, MD, USA), Kar-
ali (Oxoid) and Selenite medium (Bio-Rad, Marnes la
oquette, France) for enrichment. Sd1 strains were iden-
iﬁed using API 20E strips (bioMe´rieux), and conﬁrmed by
ry, Central African Republic, 2003—2004.
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Table 1 Phenotypic and molecular characteristics of the Shigella dysenteriae type 1 (Sd1) isolates under study
Isolate Date Sex/age
groupa
Geographic origin
(CAR Pre´fecture)b
Antimicrobial
resistance patternc
XbaI-PFGE
type
NotI-PFGE
type
Plasmid
proﬁled
CAR Sd1 isolates
1 Oct 03 M/IV Bozoum (OP) ASCSulTmpSxtTe X1 N1 P5
2 Oct 03 M/II Bozoum (OP) ASCSulTmpSxtTe X1 N1 P5
3 Oct 03 M/IV Paoua (OP) ASCSulTmpSxtTe X4 N2 P5
4 Oct 03 F/IV Paoua (OP) ASCSulTmpSxtTe X1 N1 P5
5 Feb 04 M/IV Balaou (OP) ACTmpTe X2 N3 P4
6 Feb 04 M/IV Taley (OP) ASCSulTmpSxtTe X3 N4 P5
7 Oct 04 F/IV Dogo-Yalo (NG) ASSpCTe X5 N5 P4
8 Oct 04 M/III Grevai (NG) ASSpCTe X5 N5 P4
9 Oct 04 M/IV Kaga-Bandoro (NG) ASSpCTe X7 N7 P4
10 Oct 04 F/III Kaga-Bandoro (NG) ASSpCSulTmpSxtTe X6 N6 P6
11 Nov 04 M/IV Bangui ASSpCTe X7 N7 P4
12 Nov 04 F/III Bangui ASSpCSulTmpSxtTe X6 N6 P6
13 Nov 04 F/III Grevai (NG) ASSpCTe X5 N5 P4
14 Nov 04 F/IV Yangoubanda (NG) ASSpCTe X5 N5 P4
15 Nov 04 F/IV Yangoubanda (NG) ASSpCTe X5 N5 P4
16 Nov 04 F/III Grevai (NG) ASSpCTe X5 N5 P4
17 Nov 04 M/II Grevai (NG) ASSpCTe X5 N5 P4
18 Nov 04 M/IV Grevai (NG) ASSpCTe X5 N5 P4
19 Dec 04 F/IV Yangoubanda (NG) ASSpCTe X5 N5 P4
Sd1 comparison strains
C1 Jan 93 F/II Madagascar ASSpCTmpTe X8 N8 P9
C2 Aug 97 F/IV Pakistan ASSpCSulTmpSxtTe X18 N17 P4
C3 Jul 99 M/IV Mali ACTmpTe X9 N9 P8
C4 Apr 99 M/IV Egypt ASSpCTmpTe X10 N10 P2
C5 Nov 99 M/IV Senegal ASCSulTmpSxtTe X11 N11 UT
C6 Dec 99 F/IV Mauritania ACTmpTe X12 N12 P7
C7 Nov 99 M/IV Egypt ASSpCTe X13 N13 P3
C8 Aug 00 F/IV Ivory Coast ACTmpTe X14 N14 P1
C9 Oct 00 M/IV Senegal ACTmpTe X15 UT UT
C10 Mar 01 F/IV Burkina-Faso ACTmpTe X16 N15 P1
C11 May 03 F/IV Niger ACTmpTe X17 N16 P4
UT: untypeable (lysis during PFGE or no plasmid detected for PP).
a Age group: I, <1 year; II, 1—5 years; III, 6—14 years; IV, 15—64 years; V, >65 years.
b Central African Republic (CAR) Pre´fectures: OP, Ouham-Pende; NG, Nana-Grebizi.
c Resistance patterns: A, amoxicillin; S, streptomycin; Sp, spectinomycin; C, chloramphenicol; Te, tetracycline; Sul, sulfonamides; Tmp,
trimethroprim; Sxt, sulfamethoxazole-trimethoprim.
d Plasmid proﬁles are shown in Figure 3.
agglutination test using monospeciﬁc Sd1 serum (Bio-Rad).
Isolates were sent to the French National Reference Cen-
ter for Escherichia coli and Shigella (NRCECS), located at
Institut Pasteur, Paris, France, for molecular typing studies.
Eleven Sd1 strains used as CS were from the NRCECS collec-
tion (Table 1). Two CS, C1 and C5, were recovered during
outbreaks in Madagascar in 1993 and in Senegal in 1999,
respectively. The remaining CS were not known to come from
outbreaks of dysentery.
2.3. Antimicrobial susceptibility testing
Antibiotic susceptibility was determined by disk diffusion on
Mueller-Hinton (MH) agar according to the guidelines of the
Antibiogram Committee of the French Society for Microbiol-
ogy (Soussy et al., 2000). The following antimicrobials (Bio-
Rad) were tested: amoxicillin (A), amoxicillin-clavulanic
acid, ticarcillin, ticarcillin-clavulanic acid, piperacillin,
piperacillin-tazobactam, cephalothin, cefamandole, cef-
operazone, cefoxitin, ceftriaxone, ceftazidime, cefepime,
aztreonam, moxalactam, imipenem, streptomycin (S),
spectinomycin (Sp), kanamycin, tobramycin, netilmicin,
gentamicin, amikacin, isepamicin, nalidixic acid (Nal),
oﬂoxacin, ciproﬂoxacin (Cip), sulphonamides (Sul),
trimethoprim (Tmp), sulfamethoxazole-trimethoprim (Sxt),
chloramphenicol (C) and tetracycline (Te). Escherichia coli
ATCC 25922 was used as a control.
2.4. Plasmid proﬁling
Plasmid DNA was puriﬁed from all the Sd1 isolates under
study by an alkaline lysis procedure (Takahashi and Nagano,
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1984) and subjected to 0.8% agarose gel electrophoresis.
Molecular sizes of plasmids were estimated using Taxotron
software (Institut Pasteur, Paris, France) by reference to
the following plasmids of known sizes (RP4, 54 kb; pIP173,
126 kb; TP116, 215 kb) and to a supercoiled DNA ladder
(Invitrogen, Groningen, The Netherlands).
2.5. Pulsed-ﬁeld gel electrophoresis
PFGE using XbaI and NotI (Roche, Mannheim, Germany) was
carried out with a CHEF-DR III system (Bio-Rad) as described
previously (Weill et al., 2004). The running conditions were
6 V/cm at 14 ◦C for 20 h (22 h with NotI) with pulse times
ramped from 2.2 to 63.8 s. Salmonella enterica serotype
Braenderup H9812 was used as molecular size marker. Image
normalization and construction of similarity matrices were
carried out using BioNumerics 4.0 (Applied Maths, Sint-
Martens-Latem, Belgium). Bands were assigned manually,
and clustering was performed using the unweighted pair-
group method with arithmetic averages (UPGMA) based on
the Dice similarity index, utilizing an optimization param-
eter of 0% and a 0.5% band position tolerance. Each pro-
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Rigure 2 Dendrograms generated by BioNumerics, showing the res
7 NotI-PFGE proﬁles (B) observed among the 30 Shigella dysenteria
sing the Dice coefﬁcient, and clustering was by unweighted pair-
epublic.ults of cluster analysis of the 18 XbaI-PFGE proﬁles (A) and the
e type 1 isolates under study. Similarity analysis was performed
group method with arithmetic averages. CAR: Central African
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ﬁle that differed by one or more bands was assigned a
type.
3. Results
3.1. Sd1 isolates
Six Sd1 strains were isolated at Institut Pasteur de Bangui
during outbreak A (among 47 specimens collected) and 11
during outbreak B (among 48 specimens collected). Two Sd1
isolates recovered from sporadic dysentery cases in Bangui
during the time of outbreak B were also included in the
study. Table 1 shows details of the 19 Sd1 isolates and the
11 CS included in this study.
3.2. Antimicrobial susceptibility testing of Sd1
isolates
All 30 Sd1 strains included in the study were resistant
to A, Te and C by disk diffusion. All strains were sus-
ceptible to extended-spectrum cephalosporins, aminoglyco-
sides, quinolones (Nal) and ﬂuoroquinolones (oﬂoxacin and
Cip). Six different antibiotic resistance phenotypes (R-types)
were observed (Table 1). ASCSulTmpSxtTe R-type was found
in ﬁve of the six CAR Sd1 isolates collected from October
2003 to February 2004. ASSpCTe R-type was found in 11 of
Figure 3 Representative plasmid proﬁles (P1 to P9) obtained
from the 28 typeable Shigella dysenteriae type 1 isolates under
study. Chromosome position is indicated by an arrowhead. M1
and M2: molecular size markers (band sizes in kilobase pairs);
M1: mix of RP4 (54 kb), pIP173 (126 kb) and TP116 (215 kb); M2:
supercoiled DNA ladder (Invitrogen).
clearly indicated that the isolates collected during outbreak
A were unrelated to those collected during outbreak B. Dur-
ing outbreak A, combined proﬁle X1/N1 was found in three
of the six isolates collected, while other isolates displayed
closely related combined proﬁles: X4/N2, X2/N3 and X3/N4.
Among the isolates collected during outbreak B, combined
proﬁle X5/N5 was found in 81.8% of the isolates (9/11), while
the remaining isolates displayed closely related combined
proﬁles: X7/N7 and X6/N6, also seen in two isolates recov-
ered from sporadic cases in Bangui in November 2004. We do
not know if the two patients had travelled to the outbreak
area or if they were in contact with a person coming from
the Kaga-Bandoro area.
3.4. Plasmid proﬁling
Nine plasmid proﬁles were seen among the 19 CAR Sd1 iso-
lates and the nine typeable CS (Table 1). Plasmid proﬁles
(P1—P9) are shown in Figure 3. Each typeable Sd1 strain
had a large plasmid, approximately 200 kb in size. Other
plasmids of various sizes (2 to 120 kb) were also detected,
depending on the pattern. Proﬁle P5 was seen in ﬁve of the
six isolates recovered during outbreak A. None of the CS
exhibited proﬁle P5. Proﬁle P4 (lacking a 7-kb plasmid com-
pared with P5) was the most frequently encountered proﬁle
in the isolates of outbreak B (10/11). It was also observed
in one isolate from outbreak A and in two CS.
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ber 2004. ACTeTmp R-type was predominant among the CS
(6/11, 55%).
3.3. Pulsed-ﬁeld gel electrophoresis
The clonal relatedness of the 19 Sd1 isolates from CAR and
the 11 Sd1 CS acquired by travellers or residents of Africa
(n = 10) or Asia (n = 1), was assessed by PFGE using XbaI and
NotI (Table 1 and Figure 2).
Seven distinct XbaI proﬁles were observed among the 19
Sd1 isolates from CAR and 11 proﬁles among the CS. XbaI-
PFGE proﬁles from CAR isolates recovered during outbreak A
(X1 to X4) belonged to one cluster, with a genetic similarity
of about 95%, while those from isolates recovered during
outbreak B (X5 to X7) were grouped in a second cluster,
with a genetic similarity of about 90%. All CS displayed dis-
tinct XbaI-PFGE proﬁles. However, proﬁles X9 and X16—X18
observed in four CS were grouped close to the cluster of pro-
ﬁles obtained from CAR isolates recovered during outbreak
A (similarity percentage of about 77%).
By using a second restriction enzyme, NotI, seven distinct
proﬁles were observed among the 19 CAR isolates and 10
among the 10 typeable CS. NotI-PFGE proﬁles from CAR Sd1
isolates were also grouped into two separate clusters. PFGE
proﬁles (N1—N4) from isolates recovered during outbreak A
belonged to a cluster with a genetic similarity of about 81%,
while those (N5—N7) from isolates recovered during out-
break B were grouped in a cluster with a genetic similarity
of about 89%. NotI-PFGE proﬁles from CS were unique. How-
ever, proﬁles N16 and N9 observed in two CS acquired in Mali
(1999) and Niger (2003) belonged to the same cluster of pro-
ﬁles obtained from CAR isolates recovered during outbreak
A. Results from XbaI- and NotI-PFGE were concordant andProﬁle P6 (with an additional 95-kb plasmid compared
ith P5) was observed in isolate 10 included in the second
utbreak and isolate 12 recovered in Bangui. Both isolates
hared PFGE combined proﬁle X6/N6 and ASSpCSuTmpSxtTe
-type. Seven proﬁles (P1—P4, P7—P9) were encountered
mong the nine typeable CS.
. Discussion
hese two outbreaks are the ﬁrst epidemics caused by Sd1
eported in CAR recently. They occurred in a country with
xtremely poor economic and sanitary conditions, particu-
arly in these remote Pre´fectures, where water supply and
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sanitation facilities were almost non-existent and health
care facilities often inoperative because of political insta-
bility. Furthermore, a large number of internally displaced
persons lived in both regions since the October 2002 to March
2003 rebellion.
The low proportion of Sd1 isolates recovered from stool
specimens (12.8 and 22.9% of the samples were positive for
Sd1 during outbreaks A and B, respectively) is possibly due to
a longer than optimal storage duration. Shigella, and espe-
cially Sd1, are fragile organisms, and the yield decreases
after the ﬁrst 2 days of storage (WHO, 2005). In our inves-
tigation, there was an average time lag of 1 week between
collection of the samples in the affected areas and their
inoculation at Institut Pasteur de Bangui. The mobile teams
were in the ﬁeld for 10 to 15 d at a time; and at the end
of their assignment, they had to drive 10 to 14 h from these
remote Pre´fectures to Bangui, due to the poor quality of
the roads (especially during the rainy season between May
and October). It would be very interesting to develop a small
mobile laboratory as an alternative solution to the problems
encountered with sample transport.
Plasmid proﬁling was the unique molecular subtyping
method used for Sd1 isolates in the past (Frost et al.,
1981, 1985; Haider et al., 1988; Gebre-Yohannes and Drasar,
1990). There were several limitations to this method due,
in particular, to the instability of plasmid DNA, with pos-
sible acquisition or loss of one or more plasmids by an
isolate. Since 1990, chromosomal DNA ﬁngerprinting tech-
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some isolates displayed different but closely related PFGE
proﬁles. This suggests that some closely related clones may
have arisen from the original clone during the outbreak. A
large outbreak affecting several hundreds or thousands of
people may facilitate chromosomal events in bacteria that
would lead to the emergence of some such closely related
clones. The diversity of the PFGE proﬁles in the CAR out-
break A, which affected 2013 patients (four combined PFGE
patterns among six isolates recovered), was higher than
those of outbreak B, affecting 445 patients (three combined
PFGE patterns among 11 isolates recovered).
The Sd1 CAR isolates were resistant to most common
antibiotics, as reported worldwide since 1972, when MDR
isolates with additional resistance to ampicillin had been
detected in Mexico (Olarte et al., 1976). Both the Sd1
CAR isolates tested, as well as the 11 CS, were suscepti-
ble to quinolones (Nal) and ﬂuoroquinolones (oﬂoxacin and
Cip). Nal-resistant Sd1 isolates were reported in Central and
Southern Africa (Rwanda since 1985 and Burundi since 1981,
Zaire in 1994, South Africa in 1995) soon after the intro-
duction of Nal as treatment for dysentery (Bogaerts et al.,
1997; Karas and Pillay, 1996; Ries et al., 1994). Susceptibil-
ity to Nal in Sd1 isolates from CAR can be explained by the
lack of Sd1 outbreaks in the past and the fact that Nal was
neither distributed, nor used, in this country, which is one
of the poorest in the world. Resistance to Nal is the ﬁrst
step towards resistance to Cip, which is now recommended
by WHO as ﬁrst-line treatment for all patients, adults and
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oiques have been developed, and it is now well established
hat PFGE using restriction enzymes XbaI and/or NotI is the
ethod of choice for molecular subtyping of Sd1 (Dutta et
l., 2003a; Kariuki et al., 1996; Pazhani et al., 2004; Soldati
nd Piffaretti, 1991; Talukder et al., 1999). Furthermore,
ulseNet’s standardized protocol for PFGE of food-borne
acterial pathogens is now widely used, facilitating inter-
ational comparisons (Hunter et al., 2005).
In the present study, we used XbaI and NotI-PFGE (with
unning conditions and a molecular size marker similar to
ulseNet’s standardized protocol, thus facilitating interna-
ional comparisons) and PP. The CAR Sd1 isolates subtyped
y PFGE were found to be different from the CS isolated in
frica from 1993 to 2003, while some of the plasmid proﬁles
ere similar. This indicates that PFGE was more discrimina-
ory than PP. This study is, to our knowledge, the ﬁrst study
hat used comprehensive molecular subtyping methods to
ssess genetic relatedness of Sd1 isolates from different
ountries in Africa. PFGE analysis indicated that there is a
enetic diversity among African Sd1 isolates. The different
eports dealing with Sd1 outbreaks in Africa suggest that the
ontinent has been experiencing an Sd1 pandemic, which
egan in 1979 in Zaire (Ebright et al., 1984; Frost et al.,
985; Kariuki et al., 1996). However, only plasmid proﬁling
as been done to support this statement. The 11 CS used for
he present study originated mostly from West Africa, and it
ould have been very interesting to perform PFGE on ear-
ier isolates from Central African outbreaks to check if the
d1 isolates from the ‘pandemic’ are linked. This genetic
iversity has even been observed in subsequent outbreaks
n the same country; such examples are the CAR, which
xperienced two outbreaks in a 1-year period, and Senegal
ith two isolates (C5 and C9), also collected during a 1-year
eriod. As observed in our study, even during an outbreakhildren during Sd1 outbreaks (WHO, 2005). Due to a recent
ntroduction of a generic version of Cip in CAR (2003), it is
ery important that we continue monitoring antimicrobial
usceptibility to quinolones by screening isolates with Nal
either by disk diffusion or by minimal inhibitory concentra-
ion [MIC] determination) and, if resistant, by performing
IC to Cip.
Antimicrobial susceptibility testing may also be very
elpful for the ﬁeld bacteriologist as a phenotypic subtyp-
ng method when molecular techniques are not available.
n this study, the different antimicrobial resistance phe-
otypes were in accord with PFGE proﬁles. Use of several
ntimicrobial disks (including antibiotics used for therapeu-
ic purposes and others used only for phenotypic expression
f resistance mechanisms) allowed us to identify different
esistance proﬁles in CAR Sd1 and then to further distinguish
he isolates. Thus, aminoglycoside Sp was useful in differ-
ntiating the isolates from outbreak A (resistant to Sp) from
hose from outbreak B (susceptible to Sp). In the same way,
oncomitant use of Sul, Tmp and Sxt disks allowed us to iden-
ify three resistance proﬁles (susceptibility to all the three
ntibiotics, resistance to Tmp alone or resistance to all the
hree antibiotics) instead of the two (susceptibility or resis-
ance to Sxt) that we would have obtained if we had used
he Sxt disk alone. However, two isolates (isolate 5 during
utbreak A and isolate 10 during outbreak B) exhibited dif-
erent antibiotic resistance from those collected during the
ame outbreak. This might be due to the acquisition (isolate
0, plasmid proﬁle 6) or the loss (isolate 5, plasmid pro-
le 4) of a plasmid carrying resistance gene(s). For a better
haracterization of the mechanisms of resistance to antibi-
tics (genes involved, plasmidic or chromosomal location
tc.) in Sd1 isolates of the present work, a genetic study is
ngoing.
Shigella dysenteriae type 1 in Central African Republic 7
In conclusion, our study was the result of a fruitful col-
laboration between ﬁeld physicians, epidemiologists and
microbiologists. The data collected will serve as the basis for
establishing long-term monitoring of Sd1 in CAR, but also, if
necessary, in neighbouring countries.
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